The phase 3 OVATION 3 trial will evaluate IMNN-001's efficacy and safety in advanced ovarian cancer patients, comparing it with standard chemotherapy. Phase 2 results demonstrated a 35% improvement in ...
Early-phase clinical trials, those first-in-human studies, are where years of research and millions in investment meet the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback